Press release
VenoVision selected for the Health Wildcatters 2022 Program in Texas to improve patient monitoring
From the Hebrew University's bench to bedsides in Dallas, TX, VenoVision brings cardiological expertise to non-invasive hemodynamic remote patient monitoring.Dallas, Texas, September 12, 2022: VenoVision was selected as one of only 11 start-ups from hundreds to participate in the Health Wildcatters 2022 Program.
VenoVision will help improve therapeutic management, patient outcomes, and drive down the billions of dollars wasted every year on preventable perioperative deterioration and rehospitalization of those suffering, or at risk of, heart failure and other hemodynamic complications.
VenoVision CSO, Prof. Yaakov Nahmias, said, "Our mission is to set a new frontier in contactless hemodynamic monitoring and accelerate the disruptive shift from conventional intervention techniques towards objective, non-invasive and continuous monitoring. Our 'point-and-press' novel technology enables a whole new market of advanced low-cost monitoring for chronic patients living a life of misery without a real cure available."
Prof. Nahmias continued, "No matter the cardiological expertise available, we want to deliver the insights previously limited to invasive catheterization to all environments. We will support medical teams to stabilize patients, specifically overcoming the challenges of non-invasively monitoring obese or overweight cardiovascular patients."
"We are very excited to work with our 5th Israeli team at Health Wildcatters, signifying the close ties and our great regard for Israeli innovation", said Hubert Zajicek, MD, CEO & Co-founder of Health Wildcatters. "Cardiac care is still one of THE top goals for any doctor and we are confident that Venovision will play an important role in improving patients lives", he said.
VenoVision was conceptualized in The Hebrew University's BioDesign program, a multidisciplinary, team-based approach to medical innovation under the supervision of Prof. Yaakov Nahmias, Ph.D., Prof. Dan Galai, Ph.D., and Prof. Dr. Tal Hasin, MD. Since then, it has completed a proof-of-concept clinical trial at Shaare Zedek Medical Center, Jerusalem, been granted its first patent in February 2022, and was a MassChallenge Israel Finalist.
On joining the Health Wildcatters 2022 program, VenoVision CEO, Jonathan Maron, said, "We are delighted to enter the extensive, open and innovative medical ecosystem of Texas as we launch our medtech venture."
With seed investment, mentorship and a tailored program, VenoVision will be working with Health Wildcatters to establish the core partnerships to initiate its milestone-based commercialization plan across product development, clinical and regulatory pathways.
VenoVision
c/o Health Wildcatters
3060 Pegasus Park Dr.
Building 6, Ste 1104
Dallas, TX 75247
USA
Website:
https://venovision.com
Press Contact:
Jonathan Maron
Co-Founder, VenoVision
jmaron@kenes.com
+972-54-940-9022
About VenoVision
VenoVision will help improve therapeutic management, patient outcomes, and drive down the billions of dollars wasted on preventable deterioration and rehospitalization by supporting medical teams to non-invasively monitor and stabilize the hemodynamics of those suffering, or at risk of, heart failure and related complications. VenoVision is a low-cost, easy-to-use, contactless, deep-thermal imaging device and hemodynamic monitoring platform for the inpatient, outpatient and home environments.
https://venovision.com
About Health Wildcatters
Health Wildcatters is the top healthcare seed accelerator in the Southwest. It is a physician-led, mentorship driven, seed investment, 12-week program, and is designed to support its start-ups to overcome the unique challenges of the healthcare industry.
https://www.healthwildcatters.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release VenoVision selected for the Health Wildcatters 2022 Program in Texas to improve patient monitoring here
News-ID: 2730557 • Views: …
More Releases for Health
Digital Therapeutics Market Research 2025 Leading Key Players - Proteus Digital …
An exclusive Digital Therapeutics Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Digital Therapeutics Market by Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report…
Digital Therapeutics Market Outlook 2025 : Proteus Digital Health, Omada Health, …
ReportsWeb.com has announced the addition of the “Global Digital Therapeutics Market Size, Status and Forecast 2025” The report focuses on major leading players with information such as company profiles, product picture and specification.
This report studies the global Digital Therapeutics market, analyzes and researches the Digital Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market,…
Digital Therapeutics Market Outlook to 2025 - Propeller Health, CANARY HEALTH, N …
The global digital therapeutics market is segmented on the basis of application, distribution channel, and geography. The application segment includes, respiratory diseases, central nervous system disease, smoking cessation, medication adherence, cardiovascular diseases, musculoskeletal diseases, and other applications. Based on distribution channel, the digital therapeutics market is segmented as, B2B and B2C.
Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and…
Digital Therapeutics Market Analysis 2018 | Growth by Top Companies: Proteus Dig …
Global Digital Therapeutics Market to 2025
This report "Digital Therapeutics Market Analysis to 2025" provides an in-depth insight of medical device industry covering all important parameters including development trends, challenges, opportunities, key manufacturers and competitive analysis.
Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and often online health technologies to treat a medical or psychological condition. The treatment relies on behavioral and…
Digital Therapeutics Market 2018 Global Key Player Analysis - Omada Health, Twin …
New Intelligence Report on “Digital Therapeutics Market to 2025” is recently published by The Insight Partners. The report aims to provide leading industry players with information such as company profiles, products and services offered, financial information of last 3 yesars, key development in past five years
North America is estimated to contribute to the largest share in the digital therapeutics market in the coming years, owing to factors such as, improved…
Digital Therapeutics Market Global Outlook to 2025 - Proteus Digital Health, Wel …
“Digital Therapeutics Market" covers a detailed research on the industry with financial analysis of the major players. The report provides key information and detailed study relating to the industry along with the Economic Impact and Regulatory and Market Support. The report examines the industry synopsis, strategic investments, Industry Surveys, Economic Impact, etc.
The market of digital therapeutics market is anticipated to grow with a significant rate in the coming years, owing…